Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep412 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

An inaugural diabetic ketoacidosis revealed by odontogenic facial cellulitis

Boukhalfa Ahmed , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: Odontogenic facial cellulitis (OFC) is a soft cellulo fatty tissue infection of lesser resistance in different spaces, delimited by the musculoaponeurotic insertions on the maxillary and mandibular bone cortices. when patients have underlying diseases such as diabetes mellitus (DM) or cancer, compromised immune systems may lead to the opportunistic progression of seemingly minor infections. We report the case of a patient who presented an inaugural diabetic ketoa...

ea0090ep461 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

About 2 rare cases of morbid obesity with syndromic character

Boubagura Imane , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: Bardet-Biedl syndrome (BBS) is a rare disorder. It is an autosomal recessive hereditary ciliopathy, including: Multivisceral impairment, associated with obesity, learning disabilities, with or without intellectual deficit. We report the observation of 2 patients followed in our training for morbid obesity.Case Report: Case 1: O. Y. 17 years old, from a non-consanguineous marriage. Admitted for management of morbid obesity, BMI=70 kg/m2...

ea0090ep497 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Meningoencephalitis revealing type 1 diabetes

Boubagura Imane , Rafi Sana , Mghari Ghizlane El , Ansari Nawal El

Introduction: Meningoencephalitis (ME) is defined as an inflammatory process of the brain and meninges, most often secondary to an infection, or more rarely to a dysimmune process. From a clinical point of view, ME is defined by the association of a neurological disorder (disorder of consciousness, convulsion) with a febrile meningeal syndrome.Case Report: The patient was 24 years old and had no previous medical history. He was admitted to the emergency ...

ea0090ep511 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Autoimmune polyendocrinopathy syndrome type 4

Ouakrim Hind , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: Autoimmune polyendocrinopathy syndrome (APS) type 4 is rare, characterized by an association between an autoimmune endocrine disease with another endocrine or non-endocrine autoimmune disease, and this association cannot be attributed to APS type 2 or 3. We report the observations of 3 cases with APS type 4.Cases presentations: Case N 1:Patient 16 years old, type 1 diabetic for 9 years under insulin therapy, with...

ea0090ep516 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Impact of morbid obesity on kidney function in type 2 diabetic patients (Experience of the obesity unit CHU Mohammed VI; Marrakech) (About 31 cases)

Boubagura Imane , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: Excess weight has become a major public health problem. Type 2 diabetes and obesity are known risk factors for kidney disease. The aim of this study is to determine the effect of obesity on glomerular filtration rate (GFR) and microalbiminuria in patients with diabetes.Methods: This is a descriptive cross-sectional study conducted over three years in obese and type 2 diabetic patients hospitalized in the Endocrinology and Diabetology Depart...

ea0090ep773 | Pituitary and Neuroendocrinology | ECE2023

Metabolic profile during Sheehan’s syndrome

Boubagura Imane , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: – Sheehan syndrome (SS), or postpartum pituitary necrosis, is a rare but potentially serious complication of postpartum. – SS remains an important cause of hypopituitarism in Morocco.– The aim of this study is to evaluate the metabolic profile of patients with SS.Materials and methods: – This is a retrospective descriptive study conducted in the endocrinology department, spread over a period of 12 years, between the year...

ea0090ep884 | Pituitary and Neuroendocrinology | ECE2023

Hypoplasia of the corpus callosum revealed by staturoponderal growth retardation: about a clinical observation

Boubagura Imane , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: The corpus callosum is the most important of the interhemispheric commissures, its fibers called callosal radiations have a transverse direction. They connect different points of the neocortex. The corpus callosum represents the neopallial commissure; it has indeed a phylogenetic development modeled on that of the neocortex. Hypoplasia of the corpus callosum is included in a rare polymalformative syndrome characterized by agenesis of the corpus callosum (CC), dis...

ea0090ep902 | Pituitary and Neuroendocrinology | ECE2023

Hyperparathyroidism and Prolactinoma: MEN1 or incidental association?

Maryame Benlafqih , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: Primary hyperparathyroidism and prolactinoma can be associated as part of a MEN1. However, the association of the two pathologies can also be seen outside of a syndrome predisposing to endocrine tumors. Case presentation: F.L., a 33-year-old woman followed for end-stage renal failure, during her follow-up hyperparathyroidism was discovered without any idea of the culprit and the victim: is the renal failure secondary to hyperparathyroidism ...

ea0090ep937 | Reproductive and Developmental Endocrinology | ECE2023

Preventing female virilisation: role of antenatal dexamethasone

Bammou Sanaa , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: Antenatal treatment with dexamethasone in pregnancies affected by congenital adrenal hyperplasias (CAH) therefore suppresses fetal androgen production and prevents virilisation of female infants. Antenatal DXM is reported to be efficacious, preventing or ameliorating virilisation in 80–85% of cases.Case report: 23-year-old patient pregnant at 6 weeks, not known of having congenital adrenal hyperplasia (CAH), concept of consanguineous m...

ea0090ep960 | Thyroid | ECE2023

Rare case of Graves’ disease resistant to methimazole: a case report

Ismail Zahra , Rafi Sana , El Mghari Ghizlane , El Ansari Nawal

Introduction: The treatment of Graves’ disease is represented principally by anti-thyroid drugs, radioiodine ablation or thyroidectomy. Methimazole is the most used drug for the initial treatment. It is rare to encounter patients with resistant hyperthyroidism despite high doses of MMI.Case presentation: A 41-year-old woman was referred to our unit for resistant thyrotoxicosis. She had a confirmed Graves’ disease with positive serum Trab. Whils...